In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Liquaemin Lock Flush Drug Master File in Korea (Liquaemin Lock Flush KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Liquaemin Lock Flush. The MFDS reviews the Liquaemin Lock Flush KDMF as part of the drug registration process and uses the information provided in the Liquaemin Lock Flush KDMF to evaluate the safety and efficacy of the drug.
After submitting a Liquaemin Lock Flush KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Liquaemin Lock Flush API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Liquaemin Lock Flush suppliers with KDMF on PharmaCompass.